Every breath counts—tiny airborne particles are hitting vulnerable hearts where patients can least afford it
Sadie Harley
Scientific Editor
Robert Egan
Associate Editor
Sanjukta Mondal
Author
PM2.5 is made up of tiny airborne particles no larger than 2.5 micrometers—about 30 times thinner than a strand of human hair. Just like any other particulate matter smaller than 10 micrometers, PM2.5 is a known health hazard because these particles are small enough to travel deep into the lungs, and some can even enter the bloodstream.
A recent study of more than 12,000 adults in China found that exposure to PM2.5 can seriously affect heart health.
The data indicated that people with valvular heart disease (VHD) who lived in areas with high levels of exposure to PM2.5 faced a greater risk of hospitalization or death due to heart failure. VHD is a condition in which the valves that regulate blood flow and direction through the heart stop functioning properly.
For every 21.80 µg/m3 increase in these particulate pollutants in the air, the risk rose by 11%. In the absence of measures to reduce air pollution, using indoor air filters and avoiding outdoor activity on highly polluted days remain the most practical ways to help protect vulnerable heart health.
The findings are published in Heart.
Impact of airborne risk factor
VHD, which can be caused by an array of factors including but not limited to rheumatic fever, congenital heart conditions, and aging of heart valves, is quietly affecting millions of lives around the world. It is more than just a heart condition, it can make everyday activities harder, reduce quality of life, and even shorten lifespan.
Despite this, the long-term outlook for patients with clinically significant VHD remains poor. Conventional VHD care is still limited to surgeries and clinical treatments, and doctors continue to rely mostly on clinical and demographic data to predict how patients with VHD will fare.
In the process, major environmental factors like air pollution, which are now increasingly recognized as a key driver of heart health, are often overlooked.
In this study, the researchers followed a large group of people to assess how air pollution affected their heart health over time.
From a national registry, they collected data of 12,258 adults across mainland China diagnosed with moderate or severe VHD. Using mathematical modeling and AI, the team estimated PM2.5 pollution levels in the areas where each patient lived, then divided the patients into three groups based on the pollution level of their locality.
Every six months for two years, the researchers checked on the patients to see whether they had been hospitalized for heart failure or had passed away.
The study found that more than 1,500 patients either died or were hospitalized for heart failure during the follow-up period. Patients living in the most polluted areas faced a 24% higher risk of these serious outcomes than those in the least polluted areas.
The data also revealed a clear pattern: as pollution levels rose, so did the risk of serious health complications. They also observed that the link between PM2.5 exposure and serious outcomes remained consistent across all groups, regardless of age, sex, smoking status, or how severe their heart disease was.
-
PM2.5 in China in 2018 and the location of the study population. PM2.5, particles with diameters ≤2.5 µm. Credit: Heart (2026). DOI: 10.1136/heartjnl-2025-327619 -
Dose-response relationship between PM2.5 exposure and risk of all-cause mortality or heart failure hospitalization among patients with valvular heart disease in unadjusted (A) and fully adjusted (B) models. Credit: Heart (2026). DOI: 10.1136/heartjnl-2025-327619
The researchers emphasize that ambient PM2.5 exposure should be taken into account in the clinical management of VHD patients and in public health practice.
Avoiding exposure by staying indoors or using air purifiers may offer temporary relief, but in the long run, stronger public health policies are needed to reduce air pollution and improve people's health outcomes.